Article

How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?

Conference|PAINWeek Conference

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Health insurance and medical care concept. Woman placing wooden blocks with health-related icons, medical care, health insurance, and medication. healthcare services, protection, insurance coverage- Image credit: Sandwish |stock.adobe.com
April 18th 2025

April 2025 Pharmacy Policy Updates

Luke Halpern, Assistant Editor Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
April 17th 2025

Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS

PT Staff Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Image credit: izzuan | stock.adobe.com
April 16th 2025

Ten Years of Telemedicine- Based Prescribing Leads to Lawsuit

Joseph L. Fink III, BSPharm, JD, DSC (Hon), FAPHA
The Tech Truth: Stepping Up as Pharmacy Technician Leaders
April 16th 2025

The Tech Truth: Stepping Up as Pharmacy Technician Leaders

Caitlin Quigley, CPhT